Meet the Levels Advisors

The Levels Advisors include key thought leaders, clinicians, and researchers in metabolic health.

Ben Bikman, PhD

Benjamin Bikman is the author of Why We Get Sick, which makes the case for insulin resistance and metabolic dysfunction as the underlying cause of many of our modern health problems. He earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. 

Currently, his professional focus as a scientist and associate professor (Brigham Young University) is to better understand the role of elevated insulin in regulating obesity and diabetes, including the relevance of ketones in mitochondrial function.

Dom D’Agostino, PhD

Dr. Dominic D’Agostino is a tenured Associate Professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine. He runs the website Keto Nutrition and has been on more than 200 podcasts talking about metabolic health.

He is also a Research Scientist at the Institute for Human and Machine Cognition (IHMC). His laboratory develops and tests metabolic-based strategies for targeting CNS oxygen toxicity (seizures), epilepsy, neurodegenerative diseases, brain cancer, and metastatic cancer.

The main focus of his lab over the last 12 years has been investigating the anticonvulsant and neuroprotective mechanism of the ketogenic diet and ketone metabolite supplementation.  This approach can be used to treat a wide variety of pathologies linked pathophysiologically to metabolic dysregulation.  Other areas of interest include researching metabolic-based drugs for cancer.

He was a research investigator and crew member on NASA’s Extreme Environment Mission Operation (NEEMO 22) and has a personal interest in environmental medicine and methods to enhance safety and physiological resilience in extreme environments. His research is supported by the Office of Naval Research (ONR), Department of Defense (DoD), private organizations, and foundations.

Sara Gottfried, MD

Dr. Gottfried is a physician-scientist who graduated from Harvard Medical School and the Massachusetts Institute of Technology and completed residency at the University of California at San Francisco. Over the past two decades, Dr. Gottfried has seen more than 25,000 patients and specializes in identifying the underlying cause of her patients’ conditions to achieve true and lasting health transformations, not just symptom management. She is more likely to assess a patient’s multi-omic profile together with next-generation biomarkers and then prescribe a personalized protocol, using primarily nutrition and lifestyle (occasionally drugs) plus other proven interventions to optimize the gene/environment interface. Her focus is executive health and elite athlete care. For nearly every patient, she designs an N-of-1 trial to provide rapid information on whether the personalized plan will improve outcomes. It’s not one method fits all. It’s not disease-centered. It’s a mission to transform healthcare, one patient at a time.

Dr. Gottfried is a global keynote speaker who practices evidence-based integrative, precision, and functional medicine. She is Clinical Assistant Professor in the Dept. of Integrative Medicine and Nutritional Sciences at Sidney Kimmel Medical College, Thomas Jefferson University, and Director of Precision Medicine at the Marcus Institute of Integrative Health. Dr. Gottfried’s research focus is metabolic phenotyping. Her three New York Times bestselling books include The Hormone CureThe Hormone Reset Diet, and Younger, and her new book, Women, Food and Hormones, is now available for preorder. Learn more here.  

Molly Maloof, MD

Dr. Molly’s mission is to radically extend healthspan—the number of years free from disease or disability—and maximize human potential by promoting wellness lifestyles that generate optimal health. She is a lecturer within the Wellness Department of the Medical School at Stanford University where she created a course entitled, “Live Better Longer: Extending Healthspan to Lengthen Lifespan.” 

Shaping the future of healthcare in her pioneering Silicon Valley medical practice and work with leading companies, Dr. Molly Maloof is on the frontier of personalized medicine, medical technology, health optimization, and scientifically-based wellness endeavors. Since 2012, she has also worked as an advisor or consultant to more than 40 companies in the digital health, consumer health, and biotechnology industries needing help with clinical strategy, product development, clinical research, and scientific marketing.

In her concierge practice, Dr. Molly provides health optimization and personalized medicine to high-achieving entrepreneurs, investors, and technology executives in San Francisco, and Silicon Valley, as well as, award-winning Hollywood actors and musicians. Unveiling the future of patient care with actionable insights on adopting the latest practices in personalized medicine, Dr. Molly challenges healthcare practitioners as well as industry influencers to re-think health and healthcare in order to reduce costs, improve patient outcomes, and improve the human condition.

David Perlmutter, MD

Dr. Perlmutter is a Board-Certified Neurologist and five-time New York Times bestselling author. He serves on the Board of Directors and is a Fellow of the American College of Nutrition. He writes and speaks extensively about the impact of metabolic dysfunction on brain health and overall health. 

Dr. Perlmutter received his M.D. degree from the University of Miami School of Medicine where he was awarded the Leonard G. Rowntree Research Award. He serves as a member of the Editorial Board for the Journal of Alzheimer’s Disease and has published extensively in peer-reviewed scientific journals including Archives of Neurology, Neurosurgery, and The Journal of Applied Nutrition. In addition, he is a frequent lecturer at symposia sponsored by institutions such as the World Bank and IMF, Columbia University, Scripps Institute, New York University, and Harvard University and serves as an Associate Professor at the University of Miami Miller School of Medicine.

Dr. Perlmutter’s books have been published in 32 languages and include the #1 New York Times bestseller Grain Brain, The Surprising Truth About Wheat, Carbs and Sugar, with over 1 million copies in print. Other New York Times bestsellers include Brain Maker, The Grain Brain Cookbook, The Grain Brain Whole Life Plan, and Brain Wash, co-written with Austin Perlmutter, M.D. He is the editor of The Microbiome and the Brain, authored by top experts in the field and published in December 2019 by CRC Press.

Gerald Shulman, MD

Dr. Shulman is the George R. Cowgill Professor of Medicine and Cellular & Molecular Physiology at Yale. He is also Co-Director of the Yale Diabetes Research Center and was an Investigator of the Howard Hughes Medical Institute for 21 years. Dr. Shulman has pioneered the use of magnetic resonance spectroscopy combined with mass spectrometry to non-invasively examine intracellular glucose and fat metabolism in humans and transgenic rodent models that have led to several paradigm shifts in our understanding of type 2 diabetes (T2D), including the molecular mechanisms by which ectopic lipid promotes liver and muscle insulin resistance, as well as developing new drugs for the treatment of T2D, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis.

Dr. Shulman is the recipient of the Stanley J. Korsymeyer Award from the American Society for Clinical Investigation, the Outstanding Clinical Investigator Award from the Endocrine Society, the Solomon Berson Award from the American Physiological Society, and the Banting Medal for Lifetime Scientific Achievement from the American Diabetes Association. Dr. Shulman is a Fellow of the American Association for the Advancement of Science, Inaugural Fellow of the American Physiological Society and he has been elected to the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine, the American Academy of Arts and Sciences and the National Academy of Sciences.